🇺🇸 Extended-release carbamazepine in United States

5 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Convulsion — 2 reports (40%)
  2. Completed Suicide — 1 report (20%)
  3. Drug Dispensing Error — 1 report (20%)
  4. Multiple Drug Overdose Intentional — 1 report (20%)

Source database →

Extended-release carbamazepine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Extended-release carbamazepine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Extended-release carbamazepine in United States?

Validus Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.